Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Zai Lab LTD Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

$15.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$27.77 - $64.4 $1.01 Million - $2.34 Million	-36,349 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $3.15 Million - $5.36 Million	30,035 Added 475.69%	36,349 $3.83 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $789,944 - $1.14 Million	6,314 New	6,314 $1.12 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$253 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$243 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$186 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$56.3 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$55 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.82B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Account